Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
7317261
Reference Type
Journal Article
Title
Eicosapentaenoic acid reduces warfarin-induced arterial calcification in rats
Author(s)
Kanai, S; Uto, K; Honda, K; Hagiwara, N; Oda, H
Year
2011
Is Peer Reviewed?
Yes
Journal
Atherosclerosis
ISSN:
0021-9150
EISSN:
1879-1484
Volume
215
Issue
1
Page Numbers
43-51
Language
English
PMID
21193197
DOI
10.1016/j.atherosclerosis.2010.12.001
Web of Science Id
WOS:000288008700007
Abstract
BACKGROUND:
Eicosapentaenoic acid (EPA), a major n-3 polyunsaturated fatty acid, is reported to have various protective effects for cardiovascular disease. However, few studies have focused on the influence of EPA on vascular calcification.
METHODS AND RESULTS:
Arterial medial calcification (AMC) was induced by administering warfarin (3 mg/g food) and vitamin K1 (1.5 mg/g food) for 2 weeks in Sprague-Dawley rats (control group), and EPA (1 g/kg/day) was administered for 2 weeks simultaneously with warfarin and vitamin K1 (EPA group) or after initiation of AMC (late EPA group). EPA showed a marked reduction of medial calcification in the EPA group, and showed a similar effect in the late EPA group. Immunohistochemical and RT-PCR analyses showed that EPA lowered the expression of osteogenetic markers, such as osteopontin, alkaline phosphatase and core binding factor-α1 in the aorta. Significant migration of macrophages with expression of matrix-metalloproteinase (MMP)-2 or MMP-9 was observed in the aortic adventitia around calcification. EPA also reduced macrophage infiltration, MMP-9 expression as well as gene expression of monocyte chemotactic protein (MCP)-1.
CONCLUSIONS:
These observations indicate that EPA attenuates arterial medial calcification through an effect associated with the suppression of MMP-9 activity and inhibition of macrophage infiltration as well as osteogenic protein expression in warfarin-induced rat models.
Keywords
Arterial medial calcification; Eicosapentaenoic acid; Macrophage; MCP-1; MMP-9; alkaline phosphatase; gelatinase A; gelatinase B; icosapentaenoic acid; monocyte chemotactic protein 1; osteopontin; phytomenadione; transcription factor RUNX2; warfarin; adventitia; animal cell; animal experiment; animal model; animal tissue; aorta; artery calcification; article; blood sampling; cell infiltration; controlled study; drug effect; drug induced disease; enzyme activity; gene expression; histopathology; immunohistochemistry; macrophage migration; male; nonhuman; priority journal; protein expression; rat; reverse transcription polymerase chain reaction; Animals; Aorta; Calcinosis; Chemokine CCL2; Eicosapentaenoic Acid; Iliac Artery; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Rats; Rats, Sprague-Dawley; Vitamin K 1; Warfarin
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity